The Medi-Cal Rx Web Portal has been updated with the following:  

• Medi-Cal Rx Web Claims Submission (WCS) User Guide. More information on User Administration Console (UAC) registration is available in the UAC Quick Start Guide. 
• Countdown to Go-Live — Are You Aware of the Cutoff Dates? includes important information and deadlines leading up to implementation of Medi-Cal Rx, effective January 1, 2022. 

Also in California, for Medi-Cal Rx updates, please visit the Department of Health Care Services’ Medi-Cal Rx: Transition website and the Medi-Cal Rx website. Medi-Cal Rx pharmacy stakeholders are strongly encouraged to sign-up for urgent announcements and other updates as they are posted to the Medi-Cal Rx website. Medi-Cal Rx will be effective January 1, 2022.  

Also in California, the Board of Pharmacy released the following Notices of Modified Text: 

• Further amending section 1715.6 to Title 16 of the California Code of Regulations related to Reporting Drug Losses.
  • Notice of Modified Text
  • Modified Text  

• Further amending section 1715.65 to Title 16 of the California Code of Regulations related to Inventory Reconciliation.
  • Notice of Modified Text
  • Modified Text  

Comments are due December 18 and can be submitted to Lori Martinez . 

Finally in California, This is a reminder that under SB 212 (2018), which established a prescription drug and sharps take-back program in California, retail pharmacies that sell a covered drug under their own label must submit written notification to the Board of Pharmacy identifying the covered entity from which the retail pharmacy obtains the covered product.  

“Covered entity” is defined under SB 212 as a manufacturer of covered products that are sold into the state. If there is not a manufacturer for a covered product, then the covered entity is the distributor of the covered product sold into the state. If there is not a manufacturer or distributor for a covered product, then the covered entity is the owner or licensee of a trademark or brand name under which covered products are sold into the state. If there is not a manufacturer, distributor, or owner or licensee of trademark or brand name, then the covered entity is the importer of the covered product into the state. 

Please click here to view the relevant provision in statute – Public Resources Code Section 42031(b).  

We have been made aware that few pharmacies required to report this information have not done so. If applicable, this is a reminder to please submit this information to the Board of Pharmacy’s Executive Officer, Anne Sodergren, at anne.sodergren@dca.ca.gov and lilly.fang@dca.ca.gov.  

For more information, contact NACDS’ Jill McCormack at 717-592-8977.